Validation requires orthogonal approaches:
Western blot: Confirm expected molecular weight (~110 kDa for Sul1) in wild-type vs. sul1Δ knockout strains .
Immunofluorescence: Compare localization patterns (e.g., plasma membrane vs. endocytosis upon sulfate addition) with tagged Sul1 constructs .
Functional assays: Test sulfate-dependent PKA activation in sul1Δ/sul2Δ double mutants .
Use direct conjugates (e.g., fluorophore-labeled Sul-1 antibodies) for spatial resolution in multiplex assays .
For signal amplification, pair unconjugated primary antibodies with species/isotype-specific secondaries (e.g., anti-rat IgG for HA-tagged Sul1) .
Transport-deficient mutants: Introduce point mutations (e.g., Sul1 E427Q) to uncouple transport from signaling .
Non-transported agonists: Use d-glucosamine 2-sulfate to isolate receptor function .
Kinetic assays: Measure PKA activation (e.g., HSP12 expression) and sulfate uptake simultaneously .
Signal amplification: Combine tyramide-based systems with indirect secondary antibodies .
Pre-clearing: Remove nonspecific antibodies using sul1Δ lysate-coated beads .
Crosslinking: Stabilize Sul-1-antibody complexes with BS³ crosslinkers before lysis .
Proximity ligation assays (PLA): Map Sul-1 interactions with PKA subunits or sulfate transporters .
Phosphorylation profiling: Use phospho-specific antibodies to track Sul-1 signaling cascades (e.g., STAT3 activation) .
CRISPRi screens: Identify genetic modifiers of Sul-1-dependent sulfate sensing .